BACKGROUND/AIMS: DNA sequences from Simian virus 40 (SV40) have been previously isolated from various human tumours of the central nervous system (CNS). This study aimed to investigate a series of tumours of the CNS for the expression of the SV40 large T antigen (Tag), which is an oncogenic protein of the virus. METHODS: A French series of 82 CNS tumours was investigated for Tag expression using a monoclonal antibody and immunohistochemistry. A Tag positive hepatocellular carcinoma cell line from transgenic mice and a kidney biopsy from a patient infected by SV40 were used as positive controls. RESULTS: None of the tumours (20 ependymomas, 20 glioblastomas, 12 oligodendrogliomas, three plexus choroid adenomas, two plexus choroid carcinomas, 15 meningiomas, and 10 medulloblastomas) contained SV40 Tag positive cells. CONCLUSIONS: The lack of SV40 Tag in 82 CNS tumours of various types is at variance with previous studies from different countries, and suggests that the virus may not be an important factor in CNS tumorigenesis, at least in French cases.
BACKGROUND/AIMS: DNA sequences from Simian virus 40 (SV40) have been previously isolated from various humantumours of the central nervous system (CNS). This study aimed to investigate a series of tumours of the CNS for the expression of the SV40 large T antigen (Tag), which is an oncogenic protein of the virus. METHODS: A French series of 82 CNS tumours was investigated for Tag expression using a monoclonal antibody and immunohistochemistry. A Tag positive hepatocellular carcinoma cell line from transgenic mice and a kidney biopsy from a patient infected by SV40 were used as positive controls. RESULTS: None of the tumours (20 ependymomas, 20 glioblastomas, 12 oligodendrogliomas, three plexus choroid adenomas, two plexus choroid carcinomas, 15 meningiomas, and 10 medulloblastomas) contained SV40 Tag positive cells. CONCLUSIONS: The lack of SV40 Tag in 82 CNS tumours of various types is at variance with previous studies from different countries, and suggests that the virus may not be an important factor in CNS tumorigenesis, at least in French cases.
Authors: A De Luca; A Baldi; V Esposito; C M Howard; L Bagella; P Rizzo; M Caputi; H I Pass; G G Giordano; F Baldi; M Carbone; A Giordano Journal: Nat Med Date: 1997-08 Impact factor: 53.440
Authors: Ingolfur Johannessen; Sunimali M Perera; Alice Gallagher; Paul A Hopwood; J Alero Thomas; Dorothy H Crawford Journal: J Gen Virol Date: 2002-01 Impact factor: 3.891
Authors: Regis A Vilchez; Charles R Madden; Claudia A Kozinetz; Steven J Halvorson; Zoe S White; Jeffrey L Jorgensen; Chris J Finch; Janet S Butel Journal: Lancet Date: 2002-03-09 Impact factor: 79.321
Authors: Rui-Mei Li; Roslyn B Mannon; David Kleiner; Maria Tsokos; Michelle Bynum; Allen D Kirk; Jeffrey B Kopp Journal: Transplantation Date: 2002-12-15 Impact factor: 4.939
Authors: Michael E Scheurer; Melissa L Bondy; Kenneth D Aldape; Thomas Albrecht; Randa El-Zein Journal: Acta Neuropathol Date: 2008-03-20 Impact factor: 17.088